HEPION PHARMACEUTICALS INC's ticker is HEPA and the CUSIP is 426897104. A total of 32 filers reported holding HEPION PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $42 | +600.0% | 53,501 | +152.8% | 0.00% | +300.0% |
| Q4 2022 | $6 | -100.0% | 21,165 | -68.8% | 0.00% | -66.7% |
| Q3 2022 | $34,000 | +161.5% | 67,802 | +195.6% | 0.00% | +200.0% |
| Q2 2022 | $13,000 | -77.2% | 22,935 | -54.1% | 0.00% | -83.3% |
| Q4 2021 | $57,000 | -74.7% | 49,959 | -56.1% | 0.01% | -72.7% |
| Q2 2021 | $225,000 | -31.6% | 113,869 | -36.4% | 0.02% | -4.3% |
| Q1 2021 | $329,000 | +316.5% | 179,030 | +1114.5% | 0.02% | +187.5% |
| Q4 2019 | $79,000 | +79.5% | 14,741 | -18.4% | 0.01% | +166.7% |
| Q3 2019 | $44,000 | – | 18,060 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 923,230 | $2,022,000 | 0.82% |
| Worth Venture Partners, LLC | 233,947 | $512,000 | 0.40% |
| PERKINS CAPITAL MANAGEMENT INC | 150,000 | $329,000 | 0.22% |
| GSA CAPITAL PARTNERS LLP | 89,067 | $195,000 | 0.03% |
| PREMIER ASSET MANAGEMENT LLC | 70,000 | $153,000 | 0.03% |
| Allen Capital Group, LLC | 23,685 | $52,000 | 0.01% |
| ZEKE CAPITAL ADVISORS, LLC | 50,000 | $110,000 | 0.01% |
| Prospera Financial Services Inc | 39,300 | $86,000 | 0.01% |
| Onex Canada Asset Management Inc. | 20,000 | $44,000 | 0.00% |
| Schonfeld Strategic Advisors LLC | 95,300 | $208,000 | 0.00% |